There is no cure for Raynaud’s disease. The condition, which causes blood vessels in the fingers and toes to overreact to cold or stress, is a lifelong tendency that can’t be permanently eliminated. The good news: for most people, Raynaud’s is manageable with a combination of lifestyle strategies and, when needed, medication that significantly reduces the frequency and severity of attacks. About 3 to 5 percent of adults worldwide have Raynaud’s, and the majority live with it comfortably once they learn their triggers.
Why There’s No Permanent Fix
Raynaud’s involves an exaggerated narrowing of small blood vessels, typically in the fingers, when exposed to cold temperatures or emotional stress. In the primary form, which has no known underlying cause, this overreaction appears to be a built-in feature of how your blood vessels behave. There’s no way to rewire that response permanently. The vasospasm threshold (the temperature at which your blood vessels clamp down) is specific to each person, and it doesn’t reset over time or with treatment.
In secondary Raynaud’s, the vascular spasms are driven by an underlying condition, most often an autoimmune disease like lupus, scleroderma, or rheumatoid arthritis. Treating the underlying disease can improve Raynaud’s symptoms, sometimes substantially, but rarely eliminates them entirely because the blood vessel damage or dysfunction that triggers the spasms tends to persist.
Primary vs. Secondary Raynaud’s
The distinction between the two types matters because it shapes how serious the condition is and how aggressively it needs to be treated. Primary Raynaud’s typically appears before age 30, often during the teenage years, and is more common in women. It runs in families and, while annoying, rarely causes lasting tissue damage. Most people with primary Raynaud’s manage well with lifestyle changes alone.
Secondary Raynaud’s is less common but more serious. Because it’s tied to diseases that can damage blood vessels over time, the attacks tend to be more severe and carry real risks. In studies of patients with scleroderma, about 22 percent developed digital ulcers, and a small percentage required amputation of affected fingers. If your Raynaud’s started after age 30, affects one hand more than the other, or comes with joint pain, skin changes, or sores on your fingertips, your doctor will likely investigate for an underlying autoimmune condition.
One key diagnostic tool is nailfold capillaroscopy, a painless exam where a doctor looks at the tiny blood vessels at the base of your fingernails under magnification. In primary Raynaud’s, these capillaries look normal. In secondary Raynaud’s linked to scleroderma, the earliest sign is the appearance of abnormally enlarged “giant” capillaries and tiny hemorrhages, visible before other symptoms develop.
Lifestyle Changes That Make the Biggest Difference
For primary Raynaud’s, lifestyle modifications are the most important part of treatment and often the only treatment needed. The core strategies are straightforward: keep your whole body warm (not just your hands), avoid rapid temperature changes, and reduce emotional stress when possible. Layered clothing, insulated gloves, chemical hand warmers, and warming your car before driving in winter all help. The goal is to prevent your core body temperature from dropping, because your body restricts blood flow to extremities when it senses overall cooling.
Smoking cessation is strongly recommended. Nicotine causes blood vessel constriction on its own, which compounds the vasospasm that’s already happening during a Raynaud’s attack. Even in cold weather, a nonsmoker with Raynaud’s will generally have better circulation to the fingers than a smoker.
Medications That Reduce Attacks
When lifestyle changes aren’t enough, medications can meaningfully reduce how often attacks happen and how painful they are. The first-line option is a class of blood pressure drugs called calcium channel blockers, which relax and widen blood vessels. A meta-analysis found these drugs reduced the frequency of Raynaud’s attacks by up to 5 percent and cut the severity of attacks by about 33 percent. In patients with scleroderma-related Raynaud’s, the improvement was even larger: a reduction of over 8 attacks per week and a 35 percent decline in symptom severity.
Topical nitrate patches, applied to the skin near affected areas, are another option. These patches release a compound that directly relaxes blood vessel walls. In clinical studies, they significantly reduced both the number and severity of attacks in people with primary and secondary Raynaud’s. They’re sometimes used as a first step alongside lifestyle changes before moving to oral medications.
These medications don’t cure Raynaud’s. They work only while you’re taking them, and symptoms return if you stop. But for many people, they transform the condition from something that disrupts daily life to something that’s barely noticeable.
Options for Severe or Treatment-Resistant Cases
A small percentage of people, particularly those with secondary Raynaud’s, don’t respond adequately to standard medications. For these patients, several more aggressive options exist.
Drugs that boost blood flow at the microvascular level have shown promise. In a randomized, placebo-controlled trial published in Circulation, patients with Raynaud’s that had resisted at least two other medications saw their attack frequency drop by about a third when treated with a blood-vessel-relaxing drug typically used for erectile dysfunction. More strikingly, capillary blood flow velocity in their fingers more than quadrupled. The treatment was well tolerated, with only 2 of 20 patients dropping out due to side effects.
Botulinum toxin injections into the hand represent another option for secondary Raynaud’s. Injected near the blood vessels of the fingers, the toxin blocks nerve signals that trigger vasospasm. Studies using a dorsal (back-of-hand) injection approach found improvements in hand function and Raynaud’s symptoms lasting approximately three months before repeat treatment is needed.
For the most severe cases, where fingers have developed ulcers or tissue death despite all medical therapy, a surgical procedure called periarterial sympathectomy can help. The surgeon strips away the tiny nerve fibers wrapped around the finger arteries that trigger spasm. In one study of patients with severe digital ischemia who had failed all medical treatments, 50 percent achieved complete ulcer healing within one month, and 100 percent healed by six months. Pain scores dropped significantly. This is a last-resort option, but it can prevent amputation in critical cases.
What Long-Term Management Looks Like
Living with Raynaud’s is less about finding a cure and more about building habits that keep attacks infrequent and mild. For the majority of people with primary Raynaud’s, that means layering up in cold weather, keeping hand warmers accessible, and knowing their personal temperature threshold. Some people go years between significant attacks once they’ve dialed in their approach.
For those with secondary Raynaud’s, long-term management also means staying on top of the underlying autoimmune condition with regular monitoring. Your doctor may check your nailfold capillaries periodically to track whether blood vessel changes are progressing. If you notice that attacks are becoming more frequent, lasting longer, or leaving sores on your fingertips, that’s a signal to revisit your treatment plan rather than something to wait out.
The condition doesn’t shorten life expectancy on its own, and primary Raynaud’s in particular carries very low risk of complications. While a permanent cure doesn’t exist today, the range of effective treatments means most people can keep Raynaud’s well controlled throughout their lives.